| __timestamp | Amphastar Pharmaceuticals, Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 1699214000 |
| Thursday, January 1, 2015 | 77347000 | 1930998000 |
| Friday, January 1, 2016 | 104189000 | 1912291000 |
| Sunday, January 1, 2017 | 90795000 | 2152011000 |
| Monday, January 1, 2018 | 106985000 | 2049560000 |
| Tuesday, January 1, 2019 | 131923000 | 2341232000 |
| Wednesday, January 1, 2020 | 143340000 | 2255165000 |
| Friday, January 1, 2021 | 199739000 | 1962596000 |
| Saturday, January 1, 2022 | 248860000 | 2231530000 |
| Sunday, January 1, 2023 | 351121000 | 2322701000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Grifols, S.A. and Amphastar Pharmaceuticals, Inc. from 2014 to 2023. Grifols, a global leader in the production of plasma-derived medicines, consistently outperformed Amphastar, with gross profits peaking at approximately 2.34 billion in 2019. Despite this, Amphastar, known for its innovative injectable and inhalation products, demonstrated impressive growth, with a staggering 585% increase in gross profit over the decade, culminating in 2023. This growth reflects Amphastar's strategic market expansions and product innovations. Meanwhile, Grifols maintained a steady performance, showcasing its resilience and market dominance. These insights highlight the dynamic nature of the pharmaceutical industry, where strategic decisions and market positioning can significantly impact financial outcomes.
Gross Profit Comparison: Merck & Co., Inc. and Amphastar Pharmaceuticals, Inc. Trends
Amgen Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Zoetis Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing GSK plc and Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Viatris Inc. and Grifols, S.A. Trends
Gross Profit Comparison: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc. Trends
BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Grifols, S.A. vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Grifols, S.A. and Travere Therapeutics, Inc. Trends
Gross Profit Comparison: Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc. Trends